Conventional and unconventional GPCR-G protein coupling
Conventional and unconventional GPCR-G protein coupling
批准号:
10405394
负责人:
Nevin Alan Lambert
金额:
$27.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2027-04-30
关键词:
AffectArrestinsCell membraneCell modelCouplingDiseaseDrug PrescriptionsDrug TargetingFDA approvedFamilyG-Protein-Coupled ReceptorsGTP-Binding ProteinsHealthHeterotrimeric GTP-Binding ProteinsHormonesHumanLigand BindingMapsModelingMolecularMolecular ConformationNeurotransmittersPharmaceutical PreparationsPharmacologyPhysiologicalPhysiologyPrevalenceProteinsReceptor SignalingSignal TransductionSignaling ProteinTransducersTranslatingdrug developmentin vivooverexpressionreceptorreceptor bindingreceptor-mediated signalingstoichiometrytreatment response
中文摘要
项目总结/摘要
G蛋白偶联受体(GPCRs)是激素、神经递质和神经递质的重要靶点,
三分之一的FDA批准的药物。这些受体通过与来自四个家族的转导蛋白偶联来发出信号
异三聚体G蛋白和四种抑制蛋白家族。最近的结构和功能研究已经定义了
一种常规的变构机制,其中配体与受体结合促进G蛋白的活化,
抑制素然而,在数百种GPCR和16种G蛋白中存在广泛的功能多样性,
并且许多生理学和药理学的实例不符合常规模型。比如说,
我们已经发现GPCR选择合适的G蛋白的机制存在显著的变异性,
一些识别非常规G蛋白决定簇的受体。我们还发现了一些
一种自相矛盾地抑制G蛋白信号而不是通常的激活的受体,一种GPCR-G
蛋白质偶联是无效的。最后,我们已经发现了与G蛋白相关的受体,
配体结合和平均释放G蛋白激活后,一种类型的反向耦合,可以解释
这种受体的特殊药理学。对GPCR介导的信号传导的完整理解将
需要更好地了解这些非常规的GPCR-G蛋白偶联机制。此外还
将有必要将在模型细胞中过表达分子的分子研究转化为
内源性表达的GPCR和G蛋白在其天然环境中,其中表达水平、化学计量
和亚细胞区室化更紧密地匹配体内情况。因此,我们将执行
研究绘制非传统的选择性决定因素,确定患病率和生理
非生产性和反向GPCR-G蛋白偶联的意义,并更好地了解
细胞膜中GPCR的构象动力学,以及这种构象景观如何随着
受体结合配体并与转换分子相互作用。
英文摘要
PROJECT SUMMARY/ABSTRACT
G protein-coupled receptors (GPCRs) are important targets of hormones, neurotransmitters and approximately
one-third of FDA-approved drugs. These receptors signal by coupling to transducer proteins from four families
of heterotrimeric G proteins and a family of four arrestins. Recent structural and functional studies have defined
a conventional allosteric mechanism whereby ligand binding to receptors promotes activation of G proteins and
arrestins. However, there is extensive functional diversity across hundreds of GPCRs and sixteen G proteins,
and many examples of physiology and pharmacology do not conform to the conventional model. For example,
we have found significant variability in the mechanism whereby GPCRs select appropriate G proteins, and
some receptors that recognize unconventional G protein determinants for selectivity. We have also found some
receptors that paradoxically inhibit G protein signaling instead of the usual activation, a type of GPCR-G
protein coupling that is unproductive. Finally, we have found receptors that associate with G proteins prior to
ligand binding and on average release G proteins after activation, a type of inverse coupling that can explain
the unusal pharmacology of such receptors. A complete understanding of GPCR-mediated signaling will
require a better understanding of these unconventional GPCR-G protein coupling mechanisms. In addition, it
will be necessary to translate molecular studies carried out with overexpressed molecules in model cells to
endogenously-expressed GPCRs and G proteins in their native context, where expression levels, stoichiometry
and subcellular compartmentalization more closely match the in vivo situation. Accordingly, we will carry out
studies to map unconventional selectivity determinants, determine the prevalence and physiological
significance of unproductive and inverse GPCR-G protein coupling, and to better understand the
conformational dynamics of GPCRs in cell membranes, and how this conformational landscape changes as
receptors bind ligands and interact with transducer molecules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conventional and unconventional GPCR-G protein coupling
-
批准号:10605361
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2022
-
负责人:Nevin Alan Lambert
-
依托单位:
Direct assessment of GPCR-transducer coupling and G protein subtype bias
-
批准号:10239055
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2018
-
负责人:Nevin Alan Lambert
-
依托单位:
Hydrophobic mismatch and self-association of TM proteins and beta2 adrenoreceptor
-
批准号:8208051
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2011
-
负责人:Nevin Alan Lambert
-
依托单位:
Hydrophobic mismatch and self-association of TM proteins and beta2 adrenoreceptor
-
批准号:8066178
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2011
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:8077523
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2010
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:7263398
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:8827367
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:7650381
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:7886647
-
项目类别:
-
资助金额:$22.78万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:8718138
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:7501237
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:9199111
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
GPCR signaling complexes in living cells
-
批准号:7797773
-
项目类别:
-
资助金额:$4.8万
-
财政年份:2007
-
负责人:Nevin Alan Lambert
-
依托单位:
CALCIUM AND ENDOCYTOTIC MEMBRANE RETRIEVAL
-
批准号:6637706
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2000
-
负责人:Nevin Alan Lambert
-
依托单位:
MECHANISM OF FUNCTIONAL PRESYNAPTIC HETEROGENEITY IN CNS
-
批准号:6393538
-
项目类别:
-
资助金额:$10.52万
-
财政年份:1997
-
负责人:Nevin Alan Lambert
-
依托单位:
Regulation of G-protein signaling in CNS neurons
-
批准号:6701826
-
项目类别:
-
资助金额:$23.77万
-
财政年份:1997
-
负责人:Nevin Alan Lambert
-
依托单位:
MECHANISM OF FUNCTIONAL PRESYNAPTIC HETEROGENEITY IN CNS
-
批准号:2685779
-
项目类别:
-
资助金额:$9.11万
-
财政年份:1997
-
负责人:Nevin Alan Lambert
-
依托单位:
MECHANISM OF FUNCTIONAL PRESYNAPTIC HETEROGENEITY IN CNS
-
批准号:6055300
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1997
-
负责人:Nevin Alan Lambert
-
依托单位:
Regulation of G-protein signaling in CNS neurons
-
批准号:6847986
-
项目类别:
-
资助金额:$23.77万
-
财政年份:1997
-
负责人:Nevin Alan Lambert
-
依托单位:
MECHANISM OF FUNCTIONAL PRESYNAPTIC HETEROGENEITY IN CNS
-
批准号:2892256
-
项目类别:
-
资助金额:$9.91万
-
财政年份:1997
-
负责人:Nevin Alan Lambert
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AT1R-G蛋白/β-arrestins通路偏好性激活在急性肾损伤中的作用及其机制
-
批准号:82104272
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:贾英丽
-
依托单位:
催产素受体Gαq与β-arrestins偏爱型信号通路在产后抑郁症中的作用
-
批准号:82104148
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:朱佳蕾
-
依托单位:
β-arrestins在DC细胞迁移及自身免疫疾病中的作用及机制研究
-
批准号:31871404
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:杜昌升
-
依托单位:
β-arrestins调节小胶质细胞M1/M2表型转化及其在阿尔兹海默病进程中的作用
-
批准号:81703488
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:方吟荃
-
依托单位:
β-arrestins保护心肌梗死的作用和机制研究
-
批准号:81670260
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:刘冲
-
依托单位:
beta-arrestins在自感光神经节细胞光信号转导中的作用和机制研究
-
批准号:31601134
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:赵欢
-
依托单位:
支气管上皮细胞恶性转化中β-arrestins的作用及其机制研究
-
批准号:81301728
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:申洪昌
-
依托单位:
β-arrestins通过ER stress/Puma调控门脉高压性胃病的机制
-
批准号:81370511
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2013
-
负责人:吴斌
-
依托单位:
β-arrestins介导甘丙肽2型受体信号转导的作用机理及其可能的抗抑郁机制
-
批准号:31171032
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:徐志卿
-
依托单位:
β-arrestins在缺血再灌注性肝损伤及其修复中的作用和机制
-
批准号:81170422
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:汪根树
-
依托单位: